Show simple item record

dc.contributor.authorXue, Ling
dc.contributor.authorSingla, Rajeev K.
dc.contributor.authorHe, Shan
dc.contributor.authorArrasate Gil, Sonia
dc.contributor.authorGonzález Díaz, Humberto
dc.contributor.authorMiao, Liyan
dc.contributor.authorShen, Bairong
dc.date2025-02-23
dc.date.accessioned2025-02-04T17:23:58Z
dc.date.available2025-02-04T17:23:58Z
dc.date.issued2024-02-23
dc.identifier.citationPhytomedicine 128 : (2024) // Article ID 155479es_ES
dc.identifier.urihttp://hdl.handle.net/10810/72237
dc.description.abstractBackground: Warfarin is a widely prescribed anticoagulant in the clinic. It has a more considerable individual variability, and many factors affect its variability. Mathematical models can quantify the quantitative impact of these factors on individual variability. Purpose: The aim is to comprehensively analyze the advanced warfarin dosing algorithm based on pharmacometrics and machine learning models of personalized warfarin dosage. Methods: A bibliometric analysis of the literature retrieved from PubMed and Scopus was performed using VOSviewer. The relevant literature that reported the precise dosage of warfarin calculation was retrieved from the database. The multiple linear regression (MLR) algorithm was excluded because a recent systematic review that mainly reviewed this algorithm has been reported. The following terms of quantitative systems pharmacology, mechanistic model, physiologically based pharmacokinetic model, artificial intelligence, machine learning, pharmacokinetic, pharmacodynamic, pharmacokinetics, pharmacodynamics, and warfarin were added as MeSH Terms or appearing in Title/Abstract into query box of PubMed, then humans and English as filter were added to retrieve the literature. Results: Bibliometric analysis revealed important co-occuring MeShH and index keywords. Further, the United States, China, and the United Kingdom were among the top countries contributing in this domain. Some studies have established personalized warfarin dosage models using pharmacometrics and machine learning-based algorithms. There were 54 related studies, including 14 pharmacometric models, 31 artificial intelligence models, and 9 model evaluations. Each model has its advantages and disadvantages. The pharmacometric model contains biological or pharmacological mechanisms in structure. The process of pharmacometric model development is very time- and labor-intensive. Machine learning is a purely data-driven approach; its parameters are more mathematical and have less biological interpretation. However, it is faster, more efficient, and less timeconsuming. Most published models of machine learning algorithms were established based on cross-sectional data sourced from the database.es_ES
dc.description.sponsorshipThis work was supported by Jiangsu Provincial Medical Key Discipline (ZDXK202247), the Key R&D Program of Jiangsu Province (BE2021644), Suzhou Health Leading Talent (GSWS2019001), Talent Project established by the Chinese Pharmaceutical Association Hospital Pharmacy Department (CPA-Z05-ZC-2023–003) and the Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD). We are also grateful to receive the financial support from grants Basque Government / Eusko Jaurlaritza (IT1558-22), SPRI ELKARTEK grants AIMOFGIF (KK-2022/00032), Ministry of Science and Innovation (PID2022-137365NB-I00), and Eusko Jaurlaritza, LANBIDE, INEVESTIGO Grants, IKERDATA 2022/IKER/000040 funded by NextGenerationEU funds of European Commission.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relationinfo:eu-repo/grantAgreement/MCIN/PID2022-137365NB-I00es_ES
dc.rightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectWarfarines_ES
dc.subjectPharmacometricses_ES
dc.subjectArtificial intelligencees_ES
dc.subjectMachine learninges_ES
dc.subjectPrecision medicationes_ES
dc.subjectPersonalized medicinees_ES
dc.titleWarfarin–A natural anticoagulant: A review of research trends for precision medicationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2024 Elsevier under CC BY-NC-ND licensees_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.phymed.2024.155479es_ES
dc.departamentoesQuímica Orgánica e Inorgánicaes_ES
dc.departamentoeuKimika Organikoa eta Ez-Organikoaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 Elsevier under CC BY-NC-ND license
Except where otherwise noted, this item's license is described as © 2024 Elsevier under CC BY-NC-ND license